Your browser doesn't support javascript.
loading
Tumour-derived leukaemia inhibitory factor is a major driver of cancer cachexia and morbidity in C26 tumour-bearing mice.
Kandarian, Susan C; Nosacka, Rachel L; Delitto, Andrea E; Judge, Andrew R; Judge, Sarah M; Ganey, John D; Moreira, Jesse D; Jackman, Robert W.
Afiliación
  • Kandarian SC; Department of Health Sciences, Boston University, Boston, MA, 02215, USA.
  • Nosacka RL; Department of Physical Therapy, University of Florida, Gainesville, FL, 32610, USA.
  • Delitto AE; Department of Oral Biology, College of Dentistry, University of Florida Health Science Center, Gainesville, FL, 32610, USA.
  • Judge AR; Department of Physical Therapy, University of Florida, Gainesville, FL, 32610, USA.
  • Judge SM; Department of Physical Therapy, University of Florida, Gainesville, FL, 32610, USA.
  • Ganey JD; Department of Health Sciences, Boston University, Boston, MA, 02215, USA.
  • Moreira JD; Department of Health Sciences, Boston University, Boston, MA, 02215, USA.
  • Jackman RW; Department of Health Sciences, Boston University, Boston, MA, 02215, USA.
J Cachexia Sarcopenia Muscle ; 9(6): 1109-1120, 2018 Dec.
Article en En | MEDLINE | ID: mdl-30270531

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Caquexia / Factor Inhibidor de Leucemia / Neoplasias Tipo de estudio: Prognostic_studies Límite: Animals Idioma: En Revista: J Cachexia Sarcopenia Muscle Año: 2018 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Caquexia / Factor Inhibidor de Leucemia / Neoplasias Tipo de estudio: Prognostic_studies Límite: Animals Idioma: En Revista: J Cachexia Sarcopenia Muscle Año: 2018 Tipo del documento: Article País de afiliación: Estados Unidos